88 related articles for article (PubMed ID: 2896489)
1. Pharmacological evaluation of in vivo tests for alpha 2-adrenoceptor blockade in the central nervous system and the effects of the enantiomers of mianserin and its aza-analog ORG 3770.
Gower AJ; Broekkamp CL; Rijk HW; Van Delft AM
Arch Int Pharmacodyn Ther; 1988; 291():185-201. PubMed ID: 2896489
[TBL] [Abstract][Full Text] [Related]
2. alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system.
Berridge TL; Gadie B; Roach AG; Tulloch IF
Br J Pharmacol; 1983 Mar; 78(3):507-15. PubMed ID: 6132641
[TBL] [Abstract][Full Text] [Related]
3. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
[TBL] [Abstract][Full Text] [Related]
4. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
Perrone MH; Luttinger D; Hamel LT; Fritz PM; Ferraino R; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):476-83. PubMed ID: 1974638
[TBL] [Abstract][Full Text] [Related]
5. Antagonism by mianserin and classical alpha-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine.
Robson RD; Antonaccio MJ; Saelens JK; Liebman J
Eur J Pharmacol; 1978 Feb; 47(4):431-42. PubMed ID: 24544
[TBL] [Abstract][Full Text] [Related]
6. An in vivo model for investigating alpha 1- and alpha 2-receptors in the CNS: studies with mianserin.
Clineschmidt BV; Flataker LM; Faison E; Holmes R
Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):59-76. PubMed ID: 44455
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic effects of some metabolites and analogues of mianserin on serotonin and alpha 1- and alpha 2-adrenergic receptors in the flexor reflex model in vivo.
Przegaliński E; Rawłów A; Dohnal-Borak I
Pol J Pharmacol Pharm; 1986; 38(1):69-75. PubMed ID: 3020532
[TBL] [Abstract][Full Text] [Related]
8. The effects of alpha-2 agonists and antagonists on gastric acid secretion.
Bernardini C; Del Tacca M; Soldani G; Martinotti E
Arch Int Pharmacodyn Ther; 1986 May; 281(1):134-44. PubMed ID: 2875694
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
Hirohashi M; Tanaka M; Suzuki I; Akashi A
Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
[TBL] [Abstract][Full Text] [Related]
10. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
Roach AG; Doxey JC; Strachan DA; Cavero I
J Pharmacol Exp Ther; 1983 Nov; 227(2):421-8. PubMed ID: 6138427
[TBL] [Abstract][Full Text] [Related]
11. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
Andén NE; Grabowska M; Strömbom U
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of S9871 or (imidazolinyl-2)-2-dihydro 2,3 benzofurane and its stereoisomers on some central and peripheral actions of alpha 2-agonists.
Joly G; Mouillé P; Schmitt H
Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):180-91. PubMed ID: 2865936
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-adrenoceptor antagonists on the mydriatic and bradycardic effects of detomidine.
Hanson CE; Hsu WH
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):291-8. PubMed ID: 2888443
[TBL] [Abstract][Full Text] [Related]
14. Pre- and postsynaptic a-adrenoceptor blockade by (imidazolinyl-2)-2-benzodioxane 1-4 (170 150): antagonistic action on the central effects of clonidine.
Dabiré H; Mouillé P; Andréjak M; Fournier B; Schmitt H
Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):252-70. PubMed ID: 6121540
[TBL] [Abstract][Full Text] [Related]
15. Mianserin--an analysis of its peripheral autonomic actions.
Doxey JC; Everitt J; Metcalf G
Eur J Pharmacol; 1978 Sep; 51(1):1-10. PubMed ID: 29761
[TBL] [Abstract][Full Text] [Related]
16. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
[TBL] [Abstract][Full Text] [Related]
17. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
[TBL] [Abstract][Full Text] [Related]
18. Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs.
Delini-Stula A
Pol J Pharmacol Pharm; 1984; 36(5):513-21. PubMed ID: 6152494
[TBL] [Abstract][Full Text] [Related]
19. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA
J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of the drug induced behavioural sleep in chicks.
Fügner A
Arzneimittelforschung; 1971 Sep; 21(9):1350-2. PubMed ID: 5171790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
